RespiCOz Expands Access to Portable Capnography as Brainiac Healthcare Moves Towards Respiratory Intelligence
Brainiac Healthcare expands RespiCOz portable capnography access to 10,000+ patients while developing new AI-driven respiratory intelligence tools.
Brainiac Healthcare is revolutionizing patient monitoring with its RespiCOz® technology, moving beyond simple hardware toward a future defined by Respiratory Intelligence (RI). As the company scales its operations, it has already seen its portable capnography devices installed in more than three countries, having been used to monitor over 10,000 patients to date.
Bridging the Gap in Respiratory Monitoring
Capnography is a critical tool in medical settings, playing a vital role in monitoring patients within operating theatres, intensive care units (ICUs), ambulances, and emergency departments. However, traditional capnography systems often face significant barriers to widespread use. Most conventional systems are designed for stationary use and are typically integrated into large, expensive multiparameter monitors. This lack of portability and high cost often limits their availability at various points of care.
RespiCOz® was engineered specifically to break these barriers. Designed as a portable alternative, the device brings essential respiratory monitoring beyond the confines of fixed clinical settings. By connecting directly to a clinician’s smartphone, it provides real-time data, including:
- End-Tidal Carbon Dioxide (EtCO₂)
- Fractional Inspired Carbon Dioxide (FiCO₂)
- Capnograph waveforms
- Respiratory rate
A Vision Born from Crisis
The journey of RespiCOz® began in 2021, sparked by the urgent needs of the COVID-19 pandemic. Krunal Prajapati, the Founder of Brainiac Healthcare, was working on ventilators for COVID-19 patients when he witnessed firsthand how timely intervention—driven by accurate monitoring—could stabilize a deteriorating patient. This experience highlighted a massive gap in the Indian market: the lack of accessible and affordable capnography devices.
After three years of intensive development, multiple iterations, and the support of government grants, the team successfully launched a solution that addresses both accessibility and affordability. The device has received professional validation; Dr. Bhavani Shankar Kodali, Chief Obstetric Anaesthesiologist at the University of Maryland and founder of capnography.com, has reviewed the device, praising it for being sensitive, easy to use, and capable of widening global access to this technology.
The Future: AI and Respiratory Intelligence
With a robust deployment base already in place, Brainiac Healthcare is now pivoting toward a more advanced phase: Respiratory Intelligence. The company is leveraging years of captured respiratory data to develop sophisticated models that make monitoring more intelligent.
This next phase focuses on expanding into Artificial Intelligence (AI) and other respiratory-focused products. By transforming raw respiratory signals into actionable data, Brainiac Healthcare aims to move from mere monitoring to providing deep insights that support more informed clinical care and better patient outcomes worldwide.